Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H30O4 |
Molecular Weight | 370.4819 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4C(C)=C[C@@]23[H]
InChI
InChIKey=IIVBFTNIGYRNQY-YQLZSBIMSA-N
InChI=1S/C23H30O4/c1-13-11-20-18(17-6-5-16(26)12-19(13)17)7-9-22(4)21(20)8-10-23(22,14(2)24)27-15(3)25/h11-12,17-18,20-21H,5-10H2,1-4H3/t17-,18-,20-,21+,22+,23+/m1/s1
Molecular Formula | C23H30O4 |
Molecular Weight | 370.4819 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:46 UTC 2023
by
admin
on
Fri Dec 15 15:41:46 UTC 2023
|
Record UNII |
83J78V5W05
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C776
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOELY (AUTHORIZED: CONTRACEPTION)
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
IOA (WITHDRAWN: CONTRACEPTION)
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
261-379-8
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
58652-20-3
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
1957
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
100000090279
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
DTXSID90207349
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
UU-158
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
SUB03449MIG
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
Nomegestrol acetate
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
C038501
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
C87244
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
91668
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
83J78V5W05
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
DB13981
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | |||
|
53744
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL1476022
Created by
admin on Fri Dec 15 15:41:46 UTC 2023 , Edited by admin on Fri Dec 15 15:41:46 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
BINDING
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
PARENT -> METABOLITE LESS ACTIVE |
NOMAC was shown to undergo hepatic metabolism via the cytochrome P450 (CYP) system (CYP3A3, 3A4, and 2A6), with hydroxylation to six primary metabolites that have little or no progestational activity.
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
at 290 nm:
EP
|
||
|
IMPURITY -> PARENT |
EP
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||